|Grant Affiliation:||Steinman: Dendritic Cells & Flavivirus Vectors|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2010-03-02|
|Study Made Public:||2010-12-16|
Neutralization activity of sera collected from mice immunized with DC-targeted SIV gag protein plus AT-2 inactivated SIV
CAVD 322 is a preclinical mouse study to see if primed SIV gag-specific T cells would help generate a neutralizing antibody response to SIV envelope in mice immunized with two doses of a DC-targeted SIV protein gag p27 based vaccine to induce SIV gag p27 specific help.
Sign in to see full information about this study and to download study data.